Business Success Elites

Biopharmaceutical

Wockhardt Zaynich FDA Approval Cracks $9B Antibiotic Market

Wockhardt Zaynich FDA Approval Cracks $9B Antibiotic Market

Wockhardt’s Zaynich FDA approval has made history as the first New Chemical Entity fully developed by an Indian pharma company to receive a US FDA nod. With an 89% efficacy rate against drug-resistant Gram-negative bacteria and eyes on a $9 billion antibiotics market, India’s pharma ambitions just got a whole lot louder.
Biocon Founder Kiran Mazumdar-Shaw Names Niece Claire as Successor to Lead Biotech Empire

Biocon Founder Kiran Mazumdar-Shaw Names Niece Claire as Successor to Lead Biotech Empire

Biocon founder Kiran Mazumdar-Shaw has formally named her niece Claire Mazumdar as her successor, marking a watershed moment in India’s biotechnology landscape. In an exclusive Fortune India interview, the 73-year-old entrepreneur revealed her succession strategy for the company she built from a garage 48 years ago. Claire, 37, currently leads Nasdaq-listed Bicara Therapeutics, a company incubated by Biocon and taken public with a ₹362 million IPO in 2024.